-
[1]
Taylor A.. Aminopeptidases:structure and function[J]. FASEB J.,
1993,7:290-298.
-
[2]
Krige D., Needham L.A., Bawden L.J.. CHR-2797:an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells[J]. Cancer Res.,
2008,68:6669-6679.
doi: 10.1158/0008-5472.CAN-07-6627
-
[3]
Jiang X.L., Zhou L., Wu Y.R.. Modulating the substrate specificity of LTA4H aminopeptidase by using chemical compounds and small-molecule-guided mutagenesis[J]. ChemBioChem,
2010,11:1120-1128.
doi: 10.1002/cbic.v11:8
-
[4]
Rutenburg A.M., Goldbarg J.A., Pineda E.P.. Leucine aminopeptidase activityobservations in patients with cancer of the pancreas and other diseases[J]. N. Engl. J. Med.,
1958,259:469-472.
doi: 10.1056/NEJM195809042591003
-
[5]
Willighagen R., Planteydt H.. Aminopeptidase activity in cancer cells[J]. Nature,
1959,183:263-264.
doi: 10.1038/183263a0
-
[6]
Umezawa H., Aoyagi T., Suda H., Hamada M., Takeuchi T.. Bestatin, an inhibitor of aminopeptidase b, produced by actinomycetes[J]. J. Antibiot.,
1976,29:97-99.
doi: 10.7164/antibiotics.29.97
-
[7]
Scornik O.A., Botbol V.. Bestatin as an experimental tool in mammals[J]. Curr. Drug Metab.,
2001,2:67-85.
doi: 10.2174/1389200013338748
-
[8]
Hitzerd S.M., Verbrugge S.E., Ossenkoppele G., Jansen G., Peters G.J.. Positioning of aminopeptidase inhibitors in next generation cancer therapy[J]. Amino Acids,
2014,46:793-808.
doi: 10.1007/s00726-013-1648-0
-
[9]
Scott L., Lamb J., Smith S., Wheatley D.N.. Single amino acid (arginine) deprivation:rapid and selective death of cultured transformed and malignant cells[J]. Br. J. Cancer,
2000,83:800-810.
doi: 10.1054/bjoc.2000.1353
-
[10]
Çalışkan B., Banoglu E.. Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors[J]. Expert Opin. Drug Discov.,
2013,8:49-63.
doi: 10.1517/17460441.2013.735228
-
[11]
Funk C.D.. Prostaglandins and leukotrienes:advances in eicosanoid biology[J]. Science,
2001,294:1871-1875.
doi: 10.1126/science.294.5548.1871
-
[12]
Haeggstr J.Z.. Structure, function, and regulation of leukotriene A4 hydrolase[J]. Am. J. Respir. Crit. Care Med.,
2000,161:S25-S31.
doi: 10.1164/ajrccm.161.supplement_1.ltta-6
-
[13]
Tanis V.M., Bacani G.M., Blevitt J.M.. Azabenzthiazole inhibitors of leukotriene A4 hydrolase[J]. Bioorg. Med. Chem. Lett.,
2012,22:7504-7511.
doi: 10.1016/j.bmcl.2012.10.036
-
[14]
Rao N.L., Dunford P.J., Xue X.H.. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton[J]. J. Pharmacol. Exp. Ther.,
2007,321:1154-1160.
doi: 10.1124/jpet.106.115436
-
[15]
Tager A.M., Luster A.D.. BLT1 and BLT2:the leukotriene B4 receptors[J]. Prostaglandins Leukot. Essent. Fatty Acids,
2003,69:123-134.
doi: 10.1016/S0952-3278(03)00073-5
-
[16]
Haeggström J.Z.. Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis[J]. J. Biol. Chem.,
2004,279:50639-50642.
doi: 10.1074/jbc.R400027200
-
[17]
Malfroy B., Kado-Fong H., Gros C.. Molecular cloning and amino acid sequence of rat kidney aminopeptidase M:a member of a super family of zincmetallohydrolases[J]. Biochem. Biophys. Res. Commun.,
1989,161:236-241.
doi: 10.1016/0006-291X(89)91586-6
-
[18]
Vallee B.L., Auld D.S.. Zinc coordination, function, and structure of zinc enzymes and other proteins[J]. Biochemistry,
1990,29:5647-5659.
doi: 10.1021/bi00476a001
-
[19]
Haeggström J.Z., Funk C.D.. Lipoxygenase and leukotriene pathways:biochemistry, biology, and roles in disease[J]. Chem. Rev.,
2011,111:5866-5898.
doi: 10.1021/cr200246d
-
[20]
Garuti L., Roberti M., Rossi T., Castelli M., Malagoli M.. Synthesis and antiproliferative activity of 3-substituted lH-indole[3, 2-d]-1, 2, 3-triazin-4(3H)-ones[J]. Eur. J. Med. Chem.,
1998,33:43-46.
doi: 10.1016/S0223-5234(99)80074-9
-
[21]
Chollet A.M., Diguarher T.L., Kucharczyk N.. Solid-phase synthesis of α-substituted 3-bisarylthio N-hydroxy propionamides as specific MMP inhibitors[J]. Bioorg. Med. Chem.,
2002,10:531-544.
doi: 10.1016/S0968-0896(01)00311-X
-
[22]
Le Diguarher T., Chollet A.M., Bertrand M.. Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors[J]. J. Med. Chem.,
2003,46:3840-3852.
doi: 10.1021/jm0307638
-
[23]
Jain A.K., Vaidya A., Ravichandran V., Kashaw S.K., Agrawal R.K.. Recent developments and biological activities of thiazolidinone derivatives:a review[J]. Bioorg. Med. Chem.,
2012,20:3378-3395.
doi: 10.1016/j.bmc.2012.03.069
-
[24]
Zhou H.Y., Wu S.H., Zhai S.M.. Synthesis cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells[J]. J. Med. Chem.,
2008,51:1242-1251.
doi: 10.1021/jm7012024
-
[25]
Karal N., Karalı N., Gürsoy A.. Synthesis and primary cytotoxicity evaluation of new 5-bromo-3-substituted-hydrazono-1H-2-indolinones[J]. Arch. Pharm.,
2002,8:374-380.
-
[26]
Thunnissen M.M.G.M., Nordlund P., Haeggström J.Z.. Crystal structure of human leukotriene A4 hydrolase, a bifunctional enzyme in inflammation[J]. Nat. Struct. Mol. Biol.,
2001,8:131-135.
doi: 10.1038/84117
-
[27]
Clark A.S., Deans B., Stevens M.F.G.. Antitumor imidazotetrazines. 32.1 synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide[J]. J. Med. Chem.,
1995,38:1493-1504.
doi: 10.1021/jm00009a010
-
[28]
P. K. S. Sarma, S. Sharma, S. Dharmarajan, et al. , Adrenergic receptor antagonists, WO 2006117760 A1.
-
[29]
Jiang X.L., Zhou L., Wei D.G.. Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives[J]. Bioorg. Med. Chem. Lett.,
2008,18:6549-6552.
doi: 10.1016/j.bmcl.2008.10.044
-
[30]
Xiao Q., Dong N.N., Yao X.. Bufexamac ameliorates LPS-induced acute lung injury in mice by targeting LTA4H[J]. H, Sci. Rep.,
2016,625298.
doi: 10.1038/srep25298
-
[31]
Pan H.L., Hu Q., Wang J.Y.. Myricetin is a novel inhibitor of human inosine 50-monophosphate dehydrogenase with anti-leukemia activity[J]. Biochem. Biophys. Res. Commun.,
2016,477:915-922.
doi: 10.1016/j.bbrc.2016.06.158
-
[32]
Trott O., Olson A.J.. AutoDock Vina:improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading[J]. J. Comput. Chem.,
2010,31:455-461.